PitchSend

Investor Presentaiton

HIGH REVENUE GROWTH OPPORTUNITY alimera Estimating over $100 million revenue in 2024 Proforma Q3 YTD Proforma Annual Revenues $90.00 $80.00 $70.00 $60.00 $50.00 $45.00 $40.00 $30.00 $20.00 $10.00 $- $90.0 $80.0 $67.1 $70.0 $64.8 $59.4 $60.0 $50.0 $40.0 $30.0 $20.0 $10.0 $- $81.5 Alimera Revenue 9ME 2021 9ME 2022 9ME 2023 Proforma YUTIQ Revenue YUTIQ Revenue Since Acquisition 2021 2022 Alimera Revenue ■Proforma YUTIQ Revenue Proforma revenue includes YUTIQ revenues recognized by EyePoint Pharmaceuticals prior to acquisition in H1 2023. Nasdaq: ALIM 4

View entire presentation